m+Medelevator.RU
← Поиск публикаций
Emerging infectious diseases · 2024

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Justman Jessica, Skalland Timothy, Moore Ayana, Amos Christopher I, Marzinke Mark A, Zangeneh Sahar Z, Kelley Colleen F, Singer Rebecca, Mayer Stockton, Hirsch-Moverman Yael, Doblecki-Lewis Susanne, Metzger David, Barranco Elizabeth, Ho Ken, Marques Ernesto T A, Powers-Fletcher Margaret, Kissinger Patricia J, Farley Jason E, Knowlton Carrie, Sobieszczyk Magdalena E, Swaminathan Shobha, Reed Domonique, Tapsoba Jean De Dieu, Emel Lynda, Bell Ian, Yuhas Krista, Schrumpf Leah, Mkumba Laura, Davis Jontraye, Lucas Jonathan, Piwowar-Manning Estelle, Ahmed Shahnaz, CoVPN 5002 COMPASS Study Team

Аннотация

During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты